Alfredo Nicodemos Cruz Santana, Telma Antunes, Juliana Monteiro de Barros,
Ronaldo Adib Kairalla, Carlos Roberto Ribeiro de Carvalho, Carmen Silvia Valente Barbas
Objective: Behcet's syndrome, or Behcet's disease (BD), is a multisystem pathology, and survival is related to pulmonary involvement.
However, it appears that different treatments correlate with different prognoses. The aim of this study was to evaluate clinical and tomographic
evolution, as well as the survival, of patients with BD-related pulmonary involvement. Methods: A retrospective review of our experience
with pulmonary manifestations in patients with BD treated at our institution between January 1, 1988 and April 30, 2006. The clinical,
radiological, treatment and survival data were obtained from medical charts. Results: We identified 9 patients with BD-related pulmonary
involvement. The mean age was 34 ± 11.5 years, and 7 of the patients were male. The radiological findings were as follows: pulmonary artery
aneurysm (PAA) in 8 patients; pulmonary embolism in 3 (translating to an incidence of 5.11 cases/100 patient-years); alveolar hemorrhage in
one; and pulmonary hypertension in one. The treatment consisted of immunosuppression with prednisone plus chlorambucil (or cyclophosphamide
or mycophenolate mofetil) in all patients, with partial or complete resolution of the PAAs. One patient with a PAA and pulmonary
hypertension also received sildenafil and warfarin, with good clinical and tomographic response (the first report in the English literature). In
our sample, the mean duration of the follow-up period was 6.52 years. The three-year survival rate was 88.8%, as was the five-year survival
rate. Conclusions:
Patients with BD-related pulmonary involvement can present good survival with immunosuppressive therapy, and BD
should be borne in mind as a possible cause of pulmonary hypertension and alveolar hemorrhage.
Keywords: Behcet Syndrome; Lung diseases, interstitial; Pulmonary circulation; Hypertension, pulmonary; Pulmonary embolism; Alveolar.